Advancing science and implementing novel, cutting edge Technologies

StemBANCC aims to provide well characterised patient derived induced pluripotent stem cell lines and associated biomaterials in an accessible and sustainable bio-bank. StemBANCC also aims to demonstrate proof of concept for the utility of induced pluripotent stem cells in drug discovery for hard-to-treat disorders.

 

 

 

Janssen Research & Development

A division of Janssen Pharmaceutica NV

Turnhoutseweg 30

B-2340 Beerse

BELGIUM

 

janssenpharmaceutica.be

 

Project leader

 
Pieter J. Peeters, PhD

Senior Director, Integrative Systems Biology
Community of Research Excellence & Advanced Technology
C.R.E.A.Te

StemBANCC WP05 Co-lead

Phone +32 14 606648
Fax +32 14 605737
E-Mail  

Project staff

 
Frank Jacobs
 
Phone +32 14 606572
E-Mail  

 

 
Miroslav Cik
 
Phone +32 14 603874 
E-Mail  

 

 
Kurt Van Baelen, PhD
Principal Scientist, Integrative Systems Biology                               
Community of Research Excellence & Advanced
Technology
CREATe
Phone +32 14 606612
E-Mail  

 

 
Marianne Tuefferd
 
E-Mail  

 

 
Ines Royaux
 StemBANCC WP04 Co-lead
Phone +32 14 605765
E-Mail  

 

 
Hua Rong Lu
 
E-Mail  

 

 
Rony Nuydens
 
E-Mail  

Institute presentation

Janssen Research & Development brings together the capabilities, culture and people representing our legacy organizations in virology, small molecules and biotechnology. We share an overarching mission: to address and solve the most important unmet medical needs of our time. As Janssen R&D, we work together to harness our combined knowledge and resources, leverage the power and promise of outstanding science, and enhance the length and quality of life for people throughout the world.

 

More than a half century ago, Dr. Paul Janssen established Janssen Pharmaceutica, N.V., a pharmaceutical research laboratory based in Beerse, Belgium. Dr. Paul, as he was known throughout the global scientific community, was a gifted and passionate scientist who refused to accept that there are limits to science and had an unceasing willingness to consider new approaches.

 

Janssen Pharmaceutica became part of the Johnson & Johnson family of companies in 1961. In time, other innovative companies led by other brilliant researchers and entrepreneurs joined the Johnson & Johnson family of companies: in 1999, Johnson & Johnson acquired, Centocor, Inc. (now known as Janssen Biotech, Inc.), a leader in monoclonal antibody technology and acute vascular care and immunology products, in one of the largest biotech deals at the time and in 2002, Tibotec, Inc., a company dedicated to the discovery and development of innovative new drugs for HIV/AIDS and other infectious diseases, joined the Johnson & Johnson family of companies. The spirit of innovation, and the belief that science done well can benefit humanity, has been an integral part of the last 50 years of pharmaceuticals within the Johnson & Johnson family of companies and continues to live on at the Janssen companies.

 

Today, we have thousands of committed employees in many innovative companies located around the world. We are focused on developing novel treatments in five major therapeutic areas: neuroscience, infectious diseases and vaccines, oncology, immunology and cardiovascular/metabolism.

 

Contributing to this project will be especially the departments CREATe, Neuroscience Discovery and Tox/Path located amongst others in Beerse Belgium. The contribution will mainly be to the neuroscience and dug safety related work packages. Pieter Peeters is co-lead for the molecular profiling work package.

 

University Offices

Wellington Square

Oxford, OX1 2JD

 

ox.ac.uk

 

Departments involved:

Nuffield Department of Clinical Neurosciences (NDCN)

Sir William Dunn School of Pathology

Department of Physiology, Anatomy & Genetics

Oxford Centre for Diabetes, Endocrinology, and Metabolism (OCDEM)

Centre for Health, Law and Emerging Technologies (HeLEX)

Department of Psychiatry

Department of Chemistry

Department of Pharmacology

The Wellcome Trust Centre for Human Genetics

Department of Physiology, Anatomy & Genetics (MRC)

 

University of Oxford

Nuffield Department of Clinical Neurosciences (NDCN)

Level 6, West Wing, John Radcliffe Hospital

Oxford, OX3 9DU

 

ndcn.ox.ac.uk

 

Project leader

 
Dr. Zam Cader
StemBANCC Managing Entity & Lead WP1, WP7
Phone +44 (0)1865 231858
Fax +44 (0)1865 234830
E-Mail  

 

 
Dr. David Bennett
WP2, WP7
E-Mail  
 
Deidre Newman
WP2 co-lead
E-Mail  

 

Institute presentation

NDCN is one of the largest clinical neuroscience departments in Europe. It comprises 4 divisions namely Clinical Neurology, Nuffield Laboratory of Ophthalmology, Anaesthetics and Functional Magnetic Resonance Imaging of the Brain. NDCN has an established

research and teaching portfolio with a national and international reputation for excellence.

Back to top


University of Oxford

Sir William Dunn School of Pathology

South Parks Road

OX1 3RE, Oxford

 

path.ox.ac.uk

Project leader

 
Dr. Sally Cowley
Lead WP4
Phone +44 (0)1865 275600
Fax +44 (0)1865 275515
E-Mail  

 

Institute presentation

The Sir William Dunn School of Pathology is one of the largest science Departments in the University of Oxford, employing around 300 people. It teaches physiology and medicine to undergraduates and has an extensive research programme covering bacteriology and virology, cell biology, immunology and molecular biology. The Dunn School is famous for pioneering work on penicillin, which brought in the antibiotic era.

Back to top


University of Oxford

Department of Physiology, Anatomy and Genetics
Le Gros Clark Building, South Parks Road
OX1 3QX, Oxford

 

dpag.ox.ac.uk

 

Project leader

 
Dr. Richard Wade-Martins
Lead WP8
Phone +44 (0)1865 282837
Fax +44 (0)1865 272420
E-Mail  

Institute presentation

The Department of Physiology, Anatomy and Genetics is the largest pre-clinical department within University of Oxford. Building on an outstanding legacy in physiology and anatomy, the department has a world-class reputation in both its research and teaching. Its integrative and multidisciplinary research programmes focus on many of the major questions in modern biomedicine. Both the Oxford Parkinson’s Disease Centre (OPDC) and Laboratory of Molecular Neurodegeneration, based within the department will play a key role in the StemBANCC project.

Back to top


University of Oxford

Oxford Centre for Diabetes, Endocrinology, and Metabolism (OCDEM)
Radcliffe Department of Medicine
Churchill Hospital, Old Road, Headington
Oxford OX3 7LJ

 

ocdem.ox.ac.uk

 

Project leader

 
Prof. Mark McCarthy
Lead WP9
Phone +44 (0)1865 857298
Fax +44 (0)1865 857299
E-Mail  

Institute presentation

OCDEM is a pioneering centre which combines clinical care alongside research and education in diabetes, endocrinology, and metabolic disease. It is a tripartite organisation representing the University of Oxford, the National Health Service Oxford University Hospitals, and private industry.

Back to top


University of Oxford

Centre for Health, Law and Emerging Technologies (HeLEX)

Department of Public Health

Rosemary Rue Building, Old Road Campus

OX3 7LF, Oxford

 

publichealth.ox.ac.uk

 

Project leader

 
Dr. Jane Kaye
WP2
Phone +44 (0) 1865 287898
Fax +44 (0) 1865 617792
E-Mail  

Project staff

 
Dr. Michael Morrison
WP2
Phone +44 (0) 1865 287847
Fax +44 (0) 1865 617792
E-Mail  

 

 
Dr. Sarah Coy
WP2
Phone +44 (0) 1865 617762
Fax +44 (0) 1865 617792
E-Mail  

Institute presentation

The HeLEX centre specialises in investigating the relationships between law, ethics, and practice in the area of emerging technologies in health. Research at HeLEX aims to increase understanding of how the use and impact of innovative health technologies can be accommodated within existing legal and governance frameworks, and the extent to which such frameworks may need to evolve. Our current research focuses on genomics with an emphasis on biobanks, privacy, data-sharing frameworks, global governance and translational research.

Back to top


University of Oxford

Department of Psychiatry
Warneford Hospital
Oxford OX3 7JX, UK

 

psych.ox.ac.uk

 

Project leader

 
Prof. Paul Harrison
WP2
Phone +44 (0)1865 223730
Fax +44 (0)1865 251076
E-Mail  

Institute presentation

Our mission is to conduct world-class research, teach psychiatry to medical students, develop future researchers in our graduate programme, teach doctors in training, promote excellence in clinical practice, and develop and provide innovative clinical services.

We will be recruiting and phenotyping patients with bipolar disorder, and those with first episode psychosis, for StemBANCC, as part of our broader research interest in the neurobiology and treatment of these disorders.

Back to top


University of Oxford

Department of Chemistry
Mansfield Road
Oxford OX1 3TA

 

chem.ox.ac.uk

 

Project leader

 
Dr. Angela Russell
StemBANCC Managing Entity & Lead WP1, WP7
Phone +44 (0)1865 275643
Fax +44 (0)1865 275633
E-Mail  

Institute presentation

Oxford is one of the leading chemistry research departments in the world with around 80 academic staff carrying out international-level research. The Department is currently engaged in a number of innovative themes of work including: Catalysis; Sustainable Energy Chemistry; Advanced functional materials; Synthesis; Interfacial Science; Innovative Measurement and photon science; Kinetics, dynamics and mechanism; Theory and modelling of complex systems and Chemistry at the interface with biology and medicine.

Back to top


University of Oxford

Department of Pharmacology

Mansfield Road

Oxford OX1 3QT

 

pharm.ox.ac.uk

 

Project leader

 
Dr. Colin Akerman
WP8, WP11
Phone +44 (0)1865 271872
Fax +44 (0)1865 271853
E-Mail  

 

Institute presentation

The department is engaged in the investigation of basic questions concerning the interaction of chemical substances with biological systems.

Back to top


University of Oxford

The Wellcome Trust Centre for Human Genetics

Roosevelt Drive

Oxford OX3 7BN

 

www.well.ox.ac.uk/home

 

Project leader

 
Dr Rory Bowden
WP5 co-lead
Deputy Head, High-Throughput Genomics
E-Mail  

Back to top


University of Oxford

Department of Physiology, Anatomy & Genetics

MRC Functional Genomics Unit

Le Gros Clark Building, South Parks Road

OX1 3QX, Oxford

www.mrcfgu.ox.ac.uk

 

Project leader

 
Dr. Caleb Webber
WP6 leader
Phone +44 (0) 1865 285855
E-Mail  

Back to top

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.
Ok Decline